Article 26 Feb 2024 Five Years Of Activity In A Priority Sector: The European Commission's Report On Competition Enforcement In The Pharmaceutical Sector (2018-2022) European Union Anti-trust
Article 20 Feb 2024 A New EU Market Definition Notice Fit For New Market Realities? European Union Anti-trust
Article 16 Aug 2023 CAT Upholds CMA Excessive Pricing Decision In Liothyronine Tablets Case United Kingdom Litigation
Article 18 May 2023 Digital Markets Act Update: Implementing Act, Timelines, Workshops And Institutional Changes European Union Anti-trust
Article 05 May 2023 European Commission Adopts Major Reforms To EUMR Merger Review Procedures European Union Commercial
Article 10 Feb 2023 Competition Law Developments In The Pharma Sector – 2022 Round-up And What To Expect In 2023 Worldwide Anti-trust
Article 31 Oct 2022 Digital Markets Act Soon To Enter Into Force – Overview Of Key Provisions European Union Anti-trust
Article 13 Oct 2022 Update On The Teva Copaxone EU Case. The EU Commission Issues A Statement Of Objections Against Teva Over Alleged Anti-competitive Conduct Consisting Of Misuse Of Divisional Patents And A Disparagement Campaign Against Its Closest Competitor European Union IP
Article 31 May 2022 Horizon Scanning: Digital Regulation - UK And EU Developments European Union Consumer